Press Kit
Resources for journalists & partners.
Logos, product images, executive bios, and a short company description. For interview requests or additional assets, please get in touch.
Boilerplate
Leuko Labs, Inc. is developing PointCheck™, the first noninvasive device for monitoring white blood cell levels at home, without a blood draw. An MIT spin-out backed by Series A investors and NIH/NCI grants, Leuko is headquartered in Cambridge, Massachusetts with European operations in Madrid, Spain. PointCheck™ is an investigational device. It is not for sale.
Last updated May 2026.
Logos
Use the Leuko wordmark when referring to the company; and the PointCheck™ wordmark when referring to the product. Maintain clear space equal to the cap-height of the mark on all sides. Do not recolor, distort, or place on low-contrast backgrounds.
-
Leuko wordmark
Download PNG ↓ -
PointCheck™ wordmark
Download PNG ↓
SVG and dark-on-light / light-on-dark variants are available on request.
Product photography
High-resolution images of PointCheck™. Please credit “Courtesy of Leuko Labs, Inc.” when used.
-
PointCheck™ in use at home
Download ↓ -
PointCheck™ device renders
Download ↓
Executive bios
Short biographies of the Leuko executive team are maintained on the About page. Headshots available on request.